摘要:
L'invention concerne des nouveaux peptides présentant des activités hypotensive, natriurétique, diurétique, de rénovasodilatation, réno-protective, relaxant les fibres lisses, et vasorelaxantes. Les nouveaux peptides atriaux de l'invention on la formule générale (I), ou bien un sel, un ester ou un amide pharmaceutiquement acceptable de celle-ci, dans laquelle R1 est choisi entre hydrogène, AcétylArg, Aha, Arg, Cit, His, Lys, Orn et Ser-Ser; R2 représente un groupe contenant du soufre; R3 représente un acide aminé hydrophobe ou un dipeptide; R4 représente un élément d'espacement de dipeptides ou un tripeptide de la formule XY, dans laquelle X représente un élément d'espacement de dipeptides et Y représente un acide aminé basique; R5 représente un acide aminé hydrophobe; R6 représente un peptide ayant jusqu'à trois acides aminés; R7 est choisi parmi Cha, Phe, Cha-Arg, Phe-Arg, (D)Phe-Arg, Phe-(D)Arg, PhepsiArg, Leu-Arg, Ala-Arg, Arg et Gly-Ala; R8 représente un groupe contenant du soufre.
摘要:
Compounds having formula (I) are matric metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
摘要:
Compounds having formula (I) are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
摘要:
Compounds having the formula (I) are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
摘要:
L'invention se rapporte à des composés d'indole, qui sont substitués aux positions 1 ou 3 par un groupe (pyrid-3-yl)thiazolid-4-yl alkyl-, (pyrid-3-yl)thiazolid-4-oyl)-, (pyrid-3-yl)dithiolan-4-yl)alkyl- ou (pyrid-3-yl)dithiolan-4-oyl)- et qui constituent de puissants inhibiteurs du facteur d'activation des plaquettes et sont utiles dans le traitement des troubles associés au facteur d'activation des plaquettes, tels que choc septique, syndrome de la détresse respiratoire, inflammations aiguës, immunité cellulaire retardée, parturition, maturation des poumons du foetus et différenciation cellulaire.
摘要:
Compounds having the formula: (I), are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
摘要:
Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
摘要:
Compounds having formula (I) are matric metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.
摘要:
Macrocyclic compounds of formula (I) are potent inhibitors of matrix metalloproteinase and are useful in the treatment of diseases in which matrix metalloproteinase play a role. Also disclosed are matrix metalloproteinase inhibiting compositions and a method of inhibiting matrix metalloproteinase in a mammal.